Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2024 · award
Identifying novel drivers of pancreatic cancer
2024–2027 · award
Tracing clonal evolution and cell states in esophageal cancer oncogenesis
Sydney Shaffer · The Trustees Of The University Of Pennsylvania
2024–2028 · award
Personalized Recurrence Risk Prediction for Patients with Colorectal Cancer Precursors: A Digital Pathomics and Spatial Proteomics Approach
2024–2025 · award
Multivalent Peptoid Conjugates as a ‘Next-generation’ Therapy for Castration-Resistant Prostate Cancer
2024 · award
JAX - Coordination of transcription and translation in the maintenance of prolonged cell-cycle arrest
2024–2025 · award
Vanderbilt-Excellence in Cancer Research, Education, and Leadership
2024–2025 · award
Defining the replication stress response in the Alternative Lengthening of Telomeres Pathway
Rachel Flynn · Trustees Of Boston University
2024–2027 · award
Enhancing Oncolytic Virotherapy Through Inhibition of a Novel FACT-ETS-1 Antiviral Response Pathway
Don Gammon · The University Of Texas Southwestern Medical Center (ut Southwestern)
2024–2029 · award
Improving Cervical Cancer Prevention in Louisiana
Michael Hagensee · Louisiana State University Health Sciences Center New Orleans
2024–2026 · award
Function of BLM in alternative lengthening of telomeres
Haoyang Jiang · The Trustees Of The University Of Pennsylvania
2024–2029 · award
CAR T PLUS: A pilot supportive care intervention for children during CAR T cell therapy
2024–2025 · award
Targeting SWI/SNF chromatin remodeling subcomplexes in acute myeloid leukemia
2024–2025 · award
Summer Healthcare Experience (SHE) in Oncology Program
Nathan Vanderford · University Of Kentucky Research Foundation
2024–2026 · award
Multiparameter test to monitor brain tumors using cerebrospinal fluid
2024–2025 · award
Lyn kinase and immune function in mammary cancer
2024–2028 · award
Homologous recombination DNA repair deficiency as a driver of clonal evolution in pancreatic cancer
2024–2028 · award
Canine-inspired Identification and Analysis of Volatile Organic Biomarkers of Prostate Cancer using Portable GC-MS and Development of a Hand-held Nanosensor System
2024 · award
Racial disparities in the epigenetic aging of endometrial cancer
2024–2028 · award
Unlocking the Black Box: Explainable Artificial Intelligence for Breast Cancer Risk Prediction
2024–2027 · award
Dissecting the role of the mTOR pathway in tumor persistence
2024–2026 · award
Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss
2024–2025 · award
Donor NK cell therapy for pediatric myeloid malignancies
2024–2028 · award
Characterization of a nucleus-to-mitochondria ROS sensing pathway
2024–2025 · award
Genome-epigenome interactions in heritable lung cancer risk
2024 · award
Metabolic regulation of MHC-I and its importance in cancer immune evasion
2024–2025 · award
Effect of anatomical location on pancreatic cancer metabolic behavior
2024–2027 · award
Therapeutic targeting of heterotypic tumor cell networks in breast cancer metastasis
2024–2026 · award
Interrogating the therapeutic potential of CDK5 in DNA Replication
2024–2026 · award
Engineering GM-CSF as tumor immunotherapy
2024–2027 · award
Aberrant mRNA splicing as a mechanism of resistance to XRT and CAR T-cell therapy
2024–2026 · award
Personalizing and Enhancing Responses to Y-90 Radioembolization of Hepatocellular Carcinoma Using Patient-Derived Organoids and Photodynamic Therapy
2024–2027 · award
Development and Pilot Testing of a mLearning Intervention to Address Sexual Health Needs of Gynecologic Cancer Survivors
2024–2025 · award
Therapeutic Targeting of the Hdm2/HdmX E3 ligase in colorectal cancer
Julio Camarero · University Of Southern California (usc)
2024–2027 · award
Core bond of acute myeloid leukemia and cardiovascular disease uncovers a novel anti-AML strategy
Xunlei Kang · The Curators Of The University Of Missouri
2024–2027 · award
The bile acid receptor FXR suppresses Colitis-induced Colorectal Cancer
2024–2025 · award
Effect of anatomical location on pancreatic cancer metabolic behavior
2024–2026 · award
Re-activating the anti-tumor immune microenvironment while limiting adverse events using a novel directed evolution process
Brian Grindel · The University of Texas MD Anderson Cancer Center
2024–2025 · award
INFLAMMATORY BIOMARKERS IN MYELODYSPLASTIC NEOPLASMS: A PILOT STUDY
Diego Adrianzen-Herrera · University of Vermont
2024 · award
JAX - Inhibition of NEK2 as a novel therapy for viral lymphomas
2024–2028 · award